Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Ge Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-2709-8148; OpenAlex author ID A5037201895. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2024: 2 papers · 2025: 3 papers · 2026: 1 paper

Papers 6

  1. SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.drup.2026.101489↗
  2. Targeting cTRIP12 counteracts ferroptosis resistance and augments sensitivity to immunotherapy in pancreatic cancer. Co-author DOI 10.1016/j.drup.2025.101240↗
  3. TRAF3IP2-AS1 Deficiency Induces Necroptosis to Promote Pancreatic Cancer Liver Metastasis. Co-author DOI 10.1158/0008-5472.can-24-4784↗
  4. Multi-omics analyses inform mechanisms of immunotherapy response in pancreatic cancer. First author DOI 10.3389/fimmu.2025.1673098↗
  5. Targeting the MCP-GPX4/HMGB1 Axis for Effectively Triggering Immunogenic Ferroptosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/advs.202308208↗
  6. cNEK6 induces gemcitabine resistance by promoting glycolysis in pancreatic ductal adenocarcinoma via the SNRPA/PPA2c/mTORC1 axis. Co-author DOI 10.1038/s41419-024-07138-y↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zuwei Wang · 5 shared papers, 2024–2026 · strength 1.04
  2. Shi Chen · 5 shared papers, 2024–2026 · strength 1.04
  3. Cheng‐Yu Liao · 4 shared papers, 2024–2025 · strength 0.78
  4. Shun‐Cang Zhu · 4 shared papers, 2024–2025 · strength 0.78
  5. Hong-Yi Lin · 3 shared papers, 2024–2025 · strength 0.59
  6. Chengke Xie · 3 shared papers, 2024–2025 · strength 0.59
  7. Yu Pan · 2 shared papers, 2025–2026 · strength 0.46
  8. Yongding Wu · 2 shared papers, 2025 · strength 0.41
  9. Jinming Cao · 1 shared paper, 2025 · strength 0.25
  10. Mengdan Xu · 1 shared paper, 2025 · strength 0.25
  11. Mengyao Wu · 1 shared paper, 2025 · strength 0.25
  12. Dapeng Li · 1 shared paper, 2025 · strength 0.25
  13. Yecheng Li · 1 shared paper, 2025 · strength 0.25
  14. Kai Chen · 1 shared paper, 2025 · strength 0.25
  15. Haoxiang Zhang · 1 shared paper, 2025 · strength 0.20
  16. Jiangzhi Chen · 1 shared paper, 2024 · strength 0.18
  17. Yifeng Tian · 1 shared paper, 2024 · strength 0.18
  18. Yanling Chen · 1 shared paper, 2024 · strength 0.18
  19. Yanling Chen · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.